Tel Aviv's startup scene underwent a transformation around 2019, moving from a system of "Holy Grail exits," as Eli David, CEO of StartUp Link, puts it, to "building companies not looking to sell to Google right away." As has always been the case, the military is still the main source of founders--not least because almost everyone passes through it, but also for its emphasis on problem-solving and a focus on cybersecurity, AI, and robotics. There's growth in Web3, gaming, and productivity startups while countries like India are coming online as customers. "We have a brain-drain problem," admits Michel Abadi, managing partner of Maverick Ventures Israel. "But we have a lot of patience."

NeuraLight is on a mission to transform the lives of billions of people impacted by neurological disorders by digitizing neurological evaluation and care. Using their AI-driven platform to integrate multiple digital markers to accelerate and improve drug development, monitoring, and precision care for patients with neurological disorders, NeuraLight is revolutionizing patient care. NeuraLight's platform, which uses proprietary computer vision and deep learning algorithms to extract over 100 occulometic markers from facial videos captured with a standard webcam, will be used to evaluate ALS patients in a study parallel to NeuroSense's Phase IIb PARADIGM trial. PARADIGM is a double-blind, placebo-controlled study evaluating the efficacy of NeuroSense's lead combination drug candidate, PrimeC, in the treatment of ALS. The NeuroSense-NeuraLight collaboration entails sharing and tracking patient data to advance the identification and use of ALS digital biomarkers.

Their patented computer vision and deep learning algorithms extract all necessary oculometric signals from facial footage shot with a typical webcam …